2026 Pediatrics in Review Symposium

Registration is required for all live Accredited CME Events. Please be sure to register to receive the CME credit for this activity and Webex information if applicable.

CLICK HERE TO REGISTER 

The Pediatrics in Review Symposium is to allow a forum for pediatricians and pediatric sub-specialists to share knowledge regarding diagnosis, management and treatment of pediatric conditions or diseases.

1. Cystic Fibrosis in the Era of Genetic Modulators 1. Review newborn screen process for CF and its challenges 2. Introduce genetic modulator therapy including mechanism and treatment 3. Discuss outcomes in CF and future opportunities
2. New Era Biological Therapies for IBD 1. Review the diagnosis of IBD in Pediatrics 2. Discuss the treatment of IBD in the Era of Biologics 3. Discuss the potential complications of complex IBD
3. Redefining Pediatric Hearing Loss: Precision, Early Intervention, and Developmental Outcomes 1. Review why early auditory access- not screening alone- determines long-term language outcomes 2. Demonstrate how etiologic diagnosis is shifting management toward precision-based care. 3. Discuss how modern management prioritizes developmental trajectory over audiometric thresholds
4. Discussion on GLP-1’s 1. Review the latest clinical guidelines and recommendations for pharmacologic management of obesity. 2. Present updates on approved and emerging anti-obesity medications, including mechanisms of action, efficacy, and safety profiles. 3. Discuss strategies for integrating anti-obesity pharmacotherapy into individualized patient care alongside lifestyle interventions.
5. The Limits of Viability: Life after the NICU 1. Review the limits of periviability and common morbidities associated with extreme prematurity. 2. Identify the unique medical vulnerabilities of extremely preterm infants after NICU discharge. 3. Integrate evidence-based outpatient management plans, developmental care principles, and family support into primary care practice for extremely preterm infants.
6. Urticaria: It’s Often Not an Allergy — What Every Pediatrician Needs to Know 1. Differentiate acute from chronic urticaria —and recognize when allergic etiology is, and is not, the likely driver of disease. 2. Apply evidence-based guidelines for the appropriate diagnostic workup of chronic urticaria, including when allergy testing is indicated and when it should be avoided. 3. Identify stepwise treatment options for chronic urticaria including treatments beyond second-generation antihistamines, including antihistamine updosing strategies, and biologic therapies.
7. Beyond the EpiPen: Modern Treatment Strategies for IgE-Mediated Food Allergy in Children 1. Describe the mechanism, efficacy, and patient selection criteria for oral immunotherapy (OIT) in children with IgE-mediated food allergy. 2. Explain the role of omalizumab (Xolair®) as a standalone and adjunct therapy in pediatric food allergy management. 3. Counsel families on the evolving landscape of epinephrine delivery, including the FDA-approved intranasal epinephrine (Neffy®) as an alternative to auto-injectors, and review emerging data on sublingual epinephrine (not yet FDA-approved).
8. New and Emerging Therapies in Pediatric Dermatology 1. Become familiar with newer treatment options used for inflammatory disorders of the skin 2. Understand mechanisms of action 3. Review their indications for use and learn about potential side effects and implications of long term use

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Illinois State Medical Society (ISMS) through the joint providership of Endeavor Health: Edward Elmhurst Hospitals Accredited CME Program and Glenbrook Hospital. The Endeavor Health: Edward Elmhurst Hospitals program is accredited by the ISMS to provide continuing medical education for physicians. Endeavor Health: Edward-Elmhurst Hospitals designates this Live Activity activity for a maximum of 5.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Participant Credit

Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME/ISMS, please consult your professional licensing board.

Mitigation of Relevant Financial Relationships

The Endeavor Health: Edward-Elmhurst Hospitals Accredited CME Program adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited CME activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (entity whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Vincent Biank, MD
Physician
NorthShore Medical Group

Activity Administrator

Ruba Assam, MD

Faculty

Sukaina Hasnie, MD

Faculty

Nothing to disclose

Joel Joyce, MD
Physician
NorthShore Medical Group

Faculty

Paid consultant-AbbVie|Grant or research support-Aclaris|Grant or research support-Amgen|Grant or research support-Apogee|Grant or research support-CorEvitas|Grant or research support-Eli Lilly |Grant or research support-Galderma|Grant or research support-Incyte|Grant or research support-Novartis|Grant or research support-Pfizer, Inc.|Paid consultant-Regeneron|Grant or research support-Sanofi

Anil Kesavan, MD

Faculty

Nothing to disclose

Rachel Story, MD
Physician
NorthShore Medical Group

Faculty

Nothing to disclose

Kendall Ulbrich, MD
Physician
NorthShore Medical Group

Faculty

Nothing to disclose

Kimberly Watts, MD

Faculty

Nothing to disclose

Friday, May 1, 2026